93 related articles for article (PubMed ID: 21483093)
1. Associations of serum cortisol with cognitive function and dementia: the Rotterdam Study.
Schrijvers EM; Direk N; Koudstaal PJ; Kirschbaum C; Hofman A; Tiemeier H; Breteler MM
J Alzheimers Dis; 2011; 25(4):671-7. PubMed ID: 21483093
[TBL] [Abstract][Full Text] [Related]
2. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid and cognitive function and dementia.
Euser SM; Hofman A; Westendorp RG; Breteler MM
Brain; 2009 Feb; 132(Pt 2):377-82. PubMed ID: 19036766
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study.
Helmer C; Stengel B; Metzger M; Froissart M; Massy ZA; Tzourio C; Berr C; Dartigues JF
Neurology; 2011 Dec; 77(23):2043-51. PubMed ID: 22116945
[TBL] [Abstract][Full Text] [Related]
5. Measuring cognitive function with age: the influence of selection by health and survival.
Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM
Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium and cognitive function in old age.
Schram MT; Trompet S; Kamper AM; de Craen AJ; Hofman A; Euser SM; Breteler MM; Westendorp RG
J Am Geriatr Soc; 2007 Nov; 55(11):1786-92. PubMed ID: 17979900
[TBL] [Abstract][Full Text] [Related]
7. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
[TBL] [Abstract][Full Text] [Related]
8. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
[TBL] [Abstract][Full Text] [Related]
9. Silent brain infarcts and the risk of dementia and cognitive decline.
Vermeer SE; Prins ND; den Heijer T; Hofman A; Koudstaal PJ; Breteler MM
N Engl J Med; 2003 Mar; 348(13):1215-22. PubMed ID: 12660385
[TBL] [Abstract][Full Text] [Related]
10. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
[TBL] [Abstract][Full Text] [Related]
11. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.
Reitz C; den Heijer T; van Duijn C; Hofman A; Breteler MM
Neurology; 2007 Sep; 69(10):998-1005. PubMed ID: 17785668
[TBL] [Abstract][Full Text] [Related]
12. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; van der Flier WM; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
Cerebrovasc Dis; 2009; 27(4):384-91. PubMed ID: 19276621
[TBL] [Abstract][Full Text] [Related]
14. Plasma amyloid β, depression, and dementia in community-dwelling elderly.
Direk N; Schrijvers EM; de Bruijn RF; Mirza S; Hofman A; Ikram MA; Tiemeier H
J Psychiatr Res; 2013 Apr; 47(4):479-85. PubMed ID: 23312759
[TBL] [Abstract][Full Text] [Related]
15. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment.
Xu G; Zhang H; Zhang S; Fan X; Liu X
Int J Clin Pract; 2008 Jul; 62(7):1070-5. PubMed ID: 17916180
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide as a predictor of declining cognitive function and dementia--a cohort study of an elderly general population with a 5-year follow-up.
Kerola T; Nieminen T; Hartikainen S; Sulkava R; Vuolteenaho O; Kettunen R
Ann Med; 2010 Apr; 42(3):207-15. PubMed ID: 20384435
[TBL] [Abstract][Full Text] [Related]
17. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.
Podewils LJ; Guallar E; Kuller LH; Fried LP; Lopez OL; Carlson M; Lyketsos CG
Am J Epidemiol; 2005 Apr; 161(7):639-51. PubMed ID: 15781953
[TBL] [Abstract][Full Text] [Related]
18. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
Amieva H; Jacqmin-Gadda H; Orgogozo JM; Le Carret N; Helmer C; Letenneur L; Barberger-Gateau P; Fabrigoule C; Dartigues JF
Brain; 2005 May; 128(Pt 5):1093-101. PubMed ID: 15774508
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
de Bruijn RF; Janssen JA; Brugts MP; van Duijn CM; Hofman A; Koudstaal PJ; Ikram MA
J Alzheimers Dis; 2014; 42(1):137-42. PubMed ID: 24820016
[TBL] [Abstract][Full Text] [Related]
20. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly.
Kalmijn S; Launer LJ; Stolk RP; de Jong FH; Pols HA; Hofman A; Breteler MM; Lamberts SW
J Clin Endocrinol Metab; 1998 Oct; 83(10):3487-92. PubMed ID: 9768651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
